UK Renal Registry 14th Annual Report

Slides:



Advertisements
Similar presentations
UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
Advertisements

UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 9 th Annual Report 2006 Fig 13.1 ERF patients below 15 years of age, by year of data collection.
UK Renal Registry 10th Annual Report 2007 Fig 10.1 Summary of BP achievements.
UK Renal Registry 14th Annual Report Figure Summary of BP achievements.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
UK Renal Registry 15th Annual Report Figure D.1. 95% confidence limits for incidence of 108 pmp for population size 80,000–800,000.
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
UK Renal Registry 14th Annual Report Figure Consort diagram detailing incident RRT patients 2002–2006, HES admissions and ONS records included in.
UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
UK Renal Registry 9 th Annual Report 2006 Fig 14.1 Height Z scores for ERF patients aged 2 to 16 years in 2005.
UK Renal Registry 13th Annual Report
UK Renal Registry 10th Annual Report 2007
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Summary of the 2013 ERA-EDTA Registry Annual Report
South West Home Therapies Conference
UK Renal Registry 16th Annual Report
December 31st point prevalent counts by modality figure 3.1
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
Peer Review Oct 2017 Haemodialysis Graphs.
CHAPTER 5 Paediatric Renal Replacement Therapy
UK Renal Registry 13th Annual Report
ANZDATA 2014 Annual Report Chapter 11
UK Renal Registry 11th Annual Report
UK Renal Registry 11th Annual Report 2008
UK Renal Registry 13th Annual Report
Fig 6.1 Frequency of ischaemic heart disease in incident patients
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 15th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 12th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Fig 7.1 Median URR achieved in each centre, 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 12th Annual Report
UK Renal Registry 13th Annual Report
UK Renal Registry 16th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 11th Annual Report
Renal Association UK Renal Registry.
Presentation transcript:

UK Renal Registry 14th Annual Report Figure 5.1. RRT treatment used by prevalent paediatric patients <16 years old in 2010 UK Renal Registry 14th Annual Report

UK Renal Registry 14th Annual Report Figure 5.2. Treatment modality at 90 days following commencement of RRT in prevalent paediatric patients under 16 years of age in 2010 UK Renal Registry 14th Annual Report

ERF patients in 2010 for whom a causative diagnosis was reported Figure 5.3. Primary renal disease percentage in incident and prevalent paediatric ERF patients in 2010 for whom a causative diagnosis was reported UK Renal Registry 14th Annual Report

UK Renal Registry 14th Annual Report Figure 5.4. Treatment modality at day 90 after starting RRT by 5 year time period UK Renal Registry 14th Annual Report